Search results for: 'quantitative diseas analyst research'

This study provides insights across recent advances across the use of animal disease models in preclinical research.It encompasses the following aspects: Technology roadmap, market trends, capabilities, and targeted application Stakeholder activities, influence, industry initiatives Investment environment and funding support Industry evolution and ...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

New technological advances in life science instrumentation and research tools include the enhancement of next-generation sequencing (NGS) technology, digital PCR, and a wide range of informatics, robotics, and automated solutions. These improve workflow, facilitate and automate tasks, and make better use of workspaces in every area of industry. ...

17 Jan 2020  |  North America  |  Market Research

US Defense Science and Technology Research Market, Forecast to 2024

Research, Development, Testing, and Evaluation is Key to Sustaining the Most Powerful Military in the World

Infographics

×

Key Issues Addressed

The Department of Defense (DoD) relies on the technological superiority of its weapon systems and armed forces to protect US interests at home and abroad. This technological superiority is being challenged by new and evolving threats constantly being developed by potential US adversaries. To counteract these challenges, DoD’s science and technology...

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

Before the introduction of Internet of Things (IoT) technologies in healthcare, patients’ interactions with doctors were often limited to clinic visits, text or tele communications. Due to this doctors were not able to monitor patients’ health continuously and this was affecting the overall treatment outcome. To address this clinical concern, resea...